Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Entertainment
Phil Hoad

‘The masturbation scene wasn’t a big deal’: Théodore Pellerin on tackling his new film Nino’s challenges

A man on a bicycle rides toward the camera on a city street at dusk. Théodore Pellerin in Nino
Magnetic … Théodore Pellerin in Nino Photograph: © Blue Monday Productions - France 2 Cinéma

Just six months after the world rallied to defend poor Paul Dano, vulnerability may now be a hot commodity for an actor. What is “weak sauce” for Quentin Tarantino, who attacked Dano, can be mighty savoury for others. So it’s good timing that Théodore Pellerin, with his gangly frame and huge eyes, exudes that quality in the new French character study Nino. Gauche, hesitant and withholding, Pellerin is magnetic as a young Parisian locked out of his apartment for a weekend after a papillomavirus (HPV)-related cancer diagnosis.

Pellerin explains Nino’s predicament, his inability to be candid with his loved ones, almost down to the cellular level. “His throat cancer isn’t insignificant,” he says. “It’s the part that links the head to the body. There’s a dissociation from the body – a distancing of his emotions. And because it comes from a sexually transmitted disease, his sexuality – a strong life force – is stunted too. So his mission is to speak and to ejaculate.” Urgently in the case of the latter: Nino must freeze his sperm as his treatment will make him infertile. His odyssey around Paris is the gen Z answer to French New Wave classic Cléo de 5 à 7, which also revolved around a cancer diagnosis. Only this time, it’s about the impossibility of finding a good place to masturbate.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.